These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors. Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive Management of Renal Masses in Solitary Kidneys. Yasuda Y; Zhang JH; Attawettayanon W; Rathi N; Wilkins L; Roversi G; Zhang A; Accioly JPE; Shah S; Munoz-Lopez C; Palacios DA; Hofmann M; Campbell RA; Kaouk J; Haber GP; Eltemamy M; Krishnamurthi V; Abouassaly R; Martin C; Li J; Weight C; Campbell SC Eur Urol Oncol; 2023 Feb; 6(1):84-94. PubMed ID: 36517406 [TBL] [Abstract][Full Text] [Related]
10. Partial versus radical nephrectomy in very elderly patients: a propensity score analysis of surgical, functional and oncologic outcomes (RESURGE project). Mir MC; Pavan N; Capitanio U; Antonelli A; Derweesh I; Rodriguez-Faba O; Linares E; Takagi T; Rha KH; Fiori C; Maurer T; Zang C; Mottrie A; Umari P; Long JA; Fiard G; De Nunzio C; Tubaro A; Tracey AT; Ferro M; De Cobelli O; Micali S; Bevilacqua L; Torres J; Schips L; Castellucci R; Dobbs R; Quarto G; Bove P; Celia A; De Concilio B; Trombetta C; Silvestri T; Larcher A; Montorsi F; Palumbo C; Furlan M; Bindayi A; Hamilton Z; Breda A; Palou J; Aguilera A; Tanabe K; Raheem A; Amiel T; Yang B; Lima E; Crivellaro S; Perdona S; Gregorio C; Barbati G; Porpiglia F; Autorino R World J Urol; 2020 Jan; 38(1):151-158. PubMed ID: 30937569 [TBL] [Abstract][Full Text] [Related]
11. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. Mir MC; Derweesh I; Porpiglia F; Zargar H; Mottrie A; Autorino R Eur Urol; 2017 Apr; 71(4):606-617. PubMed ID: 27614693 [TBL] [Abstract][Full Text] [Related]
12. Does Reduced Renal Function Predispose to Cancer-specific Mortality from Renal Cell Carcinoma? Palacios DA; Zabor EC; Munoz-Lopez C; Roversi G; Mahmood F; Abramczyk E; Kelly M; Wilson B; Abouassaly R; Campbell SC Eur Urol; 2021 Jun; 79(6):774-780. PubMed ID: 33678521 [TBL] [Abstract][Full Text] [Related]
13. Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy? Capitanio U; Stewart GD; Klatte T; Akdogan B; Roscigno M; Marszalek M; Dell'Oglio P; Zaffuto E; Rodriguez Faba O; Salagierski M; Lingard J; Carini M; Ouzaid I; Mir MC; Montorsi F; Da Pozzo LF; Stief C; Minervini A; Brookman-May SD Eur Urol Focus; 2018 Dec; 4(6):972-977. PubMed ID: 28753867 [TBL] [Abstract][Full Text] [Related]
14. Management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management. Sun M; Becker A; Tian Z; Roghmann F; Abdollah F; Larouche A; Karakiewicz PI; Trinh QD Eur Urol; 2014 Jan; 65(1):235-41. PubMed ID: 23567066 [TBL] [Abstract][Full Text] [Related]
15. Comparison between minimally-invasive partial and radical nephrectomy for the treatment of clinical T2 renal masses: results of a 10-year study in a tertiary care center. Amparore D; Pecoraro A; Piramide F; Checcucci E; DE Cillis S; Volpi G; Piana A; Verri P; Granato S; Sica M; Manfredi M; Fiori C; Porpiglia F Minerva Urol Nephrol; 2021 Aug; 73(4):509-517. PubMed ID: 33887896 [TBL] [Abstract][Full Text] [Related]
16. Transperitoneal Robot-assisted Partial Nephrectomy with Minimum Follow-up of 5 Years: Oncological and Functional Outcomes from a Single Institution. Bertolo R; Garisto J; Dagenais J; Sagalovich D; Stein R; Fareed K; Gao T; Armanyous S; Fergany A; Lioudis M; Kaouk J Eur Urol Oncol; 2019 Mar; 2(2):207-213. PubMed ID: 31017098 [TBL] [Abstract][Full Text] [Related]
18. Partial vs. radical nephrectomy in non-metastatic pT3a kidney cancer patients: a population-based study. Pecoraro A; Amparore D; Manfredi M; Piramide F; Checcucci E; Tian Z; Peretti D; Fiori C; Karakiewicz PI; Porpiglia F Minerva Urol Nephrol; 2022 Aug; 74(4):445-451. PubMed ID: 35147387 [TBL] [Abstract][Full Text] [Related]
19. Personalized Treatment for Small Renal Tumors: Decision Analysis of Competing Causes of Mortality. Kang SK; Huang WC; Elkin EB; Pandharipande PV; Braithwaite RS Radiology; 2019 Mar; 290(3):732-743. PubMed ID: 30644815 [TBL] [Abstract][Full Text] [Related]
20. Comparison of partial vs radical nephrectomy with regard to other-cause mortality in T1 renal cell carcinoma among patients aged ≥75 years with multiple comorbidities. Sun M; Bianchi M; Trinh QD; Hansen J; Abdollah F; Hanna N; Tian Z; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI BJU Int; 2013 Jan; 111(1):67-73. PubMed ID: 22612472 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]